A detailed history of Us Bancorp \De\ transactions in United Therapeutics Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 1,779 shares of UTHR stock, worth $638,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,779
Previous 1,782 0.17%
Holding current value
$638,536
Previous $567,000 12.35%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$311.04 - $363.55 $933 - $1,090
-3 Reduced 0.17%
1,779 $637,000
Q2 2024

Aug 06, 2024

BUY
$228.26 - $319.04 $28,532 - $39,880
125 Added 7.54%
1,782 $567,000
Q1 2024

May 07, 2024

SELL
$210.76 - $249.51 $136,361 - $161,432
-647 Reduced 28.08%
1,657 $380,000
Q4 2023

Feb 09, 2024

BUY
$214.88 - $256.94 $95,836 - $114,595
446 Added 24.0%
2,304 $506,000
Q3 2023

Nov 03, 2023

SELL
$211.82 - $248.24 $38,551 - $45,179
-182 Reduced 8.92%
1,858 $419,000
Q2 2023

Aug 09, 2023

BUY
$205.19 - $232.99 $27,700 - $31,453
135 Added 7.09%
2,040 $450,000
Q1 2023

May 09, 2023

BUY
$212.99 - $276.17 $98,188 - $127,314
461 Added 31.93%
1,905 $426,000
Q4 2022

Feb 13, 2023

SELL
$205.95 - $280.43 $129,542 - $176,390
-629 Reduced 30.34%
1,444 $401,000
Q3 2022

Oct 27, 2022

BUY
$203.3 - $244.17 $27,242 - $32,718
134 Added 6.91%
2,073 $434,000
Q2 2022

Aug 01, 2022

SELL
$174.81 - $241.14 $31,640 - $43,646
-181 Reduced 8.54%
1,939 $456,000
Q1 2022

May 11, 2022

SELL
$166.16 - $213.96 $664 - $855
-4 Reduced 0.19%
2,120 $380,000
Q4 2021

Feb 11, 2022

SELL
$184.32 - $216.08 $39,997 - $46,889
-217 Reduced 9.27%
2,124 $460,000
Q3 2021

Nov 10, 2021

BUY
$179.86 - $214.88 $57,015 - $68,116
317 Added 15.66%
2,341 $433,000
Q2 2021

Aug 05, 2021

SELL
$170.47 - $211.93 $19,604 - $24,371
-115 Reduced 5.38%
2,024 $363,000
Q1 2021

Apr 28, 2021

SELL
$153.94 - $174.85 $43,257 - $49,132
-281 Reduced 11.61%
2,139 $358,000
Q4 2020

Feb 04, 2021

SELL
$101.87 - $151.79 $284,013 - $423,190
-2,788 Reduced 53.53%
2,420 $368,000
Q3 2020

Nov 10, 2020

SELL
$99.9 - $121.13 $157,842 - $191,385
-1,580 Reduced 23.28%
5,208 $526,000
Q2 2020

Aug 07, 2020

BUY
$92.74 - $125.82 $137,997 - $187,220
1,488 Added 28.08%
6,788 $821,000
Q1 2020

May 13, 2020

BUY
$79.39 - $115.35 $204,746 - $297,487
2,579 Added 94.78%
5,300 $503,000
Q4 2019

Feb 04, 2020

BUY
$78.31 - $95.34 $58,106 - $70,742
742 Added 37.49%
2,721 $240,000
Q3 2019

Nov 08, 2019

BUY
$74.85 - $85.99 $37,350 - $42,909
499 Added 33.72%
1,979 $158,000
Q2 2019

Aug 13, 2019

SELL
$76.06 - $120.81 $21,296 - $33,826
-280 Reduced 15.91%
1,480 $116,000
Q1 2019

May 08, 2019

SELL
$107.15 - $126.84 $485,496 - $574,712
-4,531 Reduced 72.02%
1,760 $207,000
Q4 2018

Feb 13, 2019

SELL
$101.4 - $128.73 $22,003 - $27,934
-217 Reduced 3.33%
6,291 $685,000
Q3 2018

Nov 01, 2018

BUY
$113.81 - $129.46 $13,315 - $15,146
117 Added 1.83%
6,508 $833,000
Q2 2018

Aug 08, 2018

BUY
$101.14 - $118.31 $87,283 - $102,101
863 Added 15.61%
6,391 $723,000
Q1 2018

May 08, 2018

BUY
$107.21 - $151.94 $21,763 - $30,843
203 Added 3.81%
5,528 $621,000
Q4 2017

Feb 02, 2018

BUY
$118.58 - $151.28 $141,703 - $180,779
1,195 Added 28.93%
5,325 $788,000
Q3 2017

Nov 13, 2017

BUY
$114.6 - $136.81 $473,298 - $565,025
4,130
4,130 $484,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.